Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Unimed discontinues U.S. registration process for nitazoxanide indication

May 18, 1998

Spotlight on AIDS vaccines

May 15, 1998

Novopharm Biotech withdraws IND for phase Ib trial of GPI-2A

May 13, 1998

Immune Network Research reports on progress of primate study evaluating 1F7 for HIV

May 12, 1998

Shaman receives fast track status for Provir

May 11, 1998

Sankyo reports glycosidase inhibitors in patent literature

May 11, 1998

Chimeric cytokine receptors for enhancing efficacy of lymphocytes in adoptive immunotherapy

May 11, 1998

Isis and Ciba Vision file MAA for fomivirsen

May 8, 1998

FDA advisory committee requests additional information on Cryptaz

May 7, 1998

BioChem Pharma initiates clinical testing of another AIDS drug

May 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...